Corrigendum to 'Genetic characterization and pathogenicity of a novel recombinant PRRSV from lineage 1, 8 and 3 in China failed to infect MARC-145 cells' [Microb. Pathog. 165 (2022) 105469]

MLA

Yang Li, et al. “Corrigendum to ‘Genetic Characterization and Pathogenicity of a Novel Recombinant PRRSV from Lineage 1, 8 and 3 in China Failed to Infect MARC-145 Cells’ [Microb. Pathog. 165 (2022) 105469].” Microbial Pathogenesis, vol. 167, June 2022, p. 105547. EBSCOhost, https://doi.org/10.1016/j.micpath.2022.105547.

APA

Yang Li, Dian Jiao, Yang Jing, Yuan He, Weiguo Han, Zhiwei Li, Zhiqian Ma, Yingtong Feng, & Shuqi Xiao. (2022). Corrigendum to “Genetic characterization and pathogenicity of a novel recombinant PRRSV from lineage 1, 8 and 3 in China failed to infect MARC-145 cells” [Microb. Pathog. 165 (2022) 105469]. Microbial Pathogenesis, 167, 105547. https://doi.org/10.1016/j.micpath.2022.105547

Chicago

Yang Li, Dian Jiao, Yang Jing, Yuan He, Weiguo Han, Zhiwei Li, Zhiqian Ma, Yingtong Feng, and Shuqi Xiao. 2022. “Corrigendum to ‘Genetic Characterization and Pathogenicity of a Novel Recombinant PRRSV from Lineage 1, 8 and 3 in China Failed to Infect MARC-145 Cells’ [Microb. Pathog. 165 (2022) 105469].” Microbial Pathogenesis 167 (June): 105547. doi:10.1016/j.micpath.2022.105547.